Literature DB >> 12633819

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

Anil-Martin Sinha1, Karsten Filzmaier, Ole-Alexander Breithardt, Dagmar Kunz, Jürgen Graf, Kai U Markus, Peter Hanrath, Christoph Stellbrink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12633819     DOI： 10.1016/s0002-9149(02)03425-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.

Authors:  J Soongswang; C Sangtawesin; K Durongpisitkul; D Laohaprasitiporn; A Nana; K Punlee; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?

Authors:  M Anderson
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

3.  Biventricular pacing reduces ventricular arrhythmic burden and defibrillator therapies in patients with heart failure.

Authors:  Andrew Voigt; William Barrington; Ogundu Ngwu; Sandeep Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

4.  Cardiac resynchronization therapy for left ventricular dysfunction induced by chronic right ventricular pacing in a child.

Authors:  Hyung Woo Kim; Gi Beom Kim; Eun Jung Bae; Chung Il Noh; Woong-Han Kim; Hae-Soon Kim
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

Review 5.  [Are neurohumoral parameters predictive for the efficacy of cardiac resynchronization therapy? The role of natriuretic peptides].

Authors:  A-M Sinha; O-A Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006

6.  Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.

Authors:  Alaa A Shalaby; William T Abraham; Gregg C Fonarow; Malcolm M Bersohn; John Gorcsan; Li-Yin Lee; Jasmina Halilovic; Samir Saba; Alan Maisel; Jagmeet P Singh; Ali Sonel; Alan Kadish
Journal:  Pacing Clin Electrophysiol       Date:  2015-03-30       Impact factor: 1.976

Review 7.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 8.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

9.  SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.

Authors:  Kenneth M Stein; Kenneth A Ellenbogen; Michael R Gold; Bernd Lemke; Ignacio Fernández Lozano; Suneet Mittal; Francis G Spinale; Jennifer E Van Eyk; Alan D Waggoner; Timothy E Meyer
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-10       Impact factor: 1.976

Review 10.  [Electrotherapy of cardiac failure].

Authors:  C Stellbrink
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.834
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.